2019
Incidence and Risk Factors of Second Malignancies Among Medicare Beneficiaries with Newly-Diagnosed Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms Receiving Cytoreductive Therapy with Hydroxyurea
Wang R, Shallis R, Huntington S, Zeidan A, Gore S, Davidoff A, Ma X, Podoltsev N. Incidence and Risk Factors of Second Malignancies Among Medicare Beneficiaries with Newly-Diagnosed Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms Receiving Cytoreductive Therapy with Hydroxyurea. Blood 2019, 134: 330. DOI: 10.1182/blood-2019-127568.Peer-Reviewed Original ResearchMyeloid hematological malignanciesHU usersPopulation-based studyHematological malignanciesCumulative incidenceCelgene CorporationMPN diagnosisCytoreductive therapySolid malignanciesGray's testPolycythemia veraMPN patientsEssential thrombocythemiaContinuous Part D coverageBoehringer IngelheimAdvisory CommitteeLarge population-based studyDaiichi SankyoImpact of hydroxyureaRetrospective cohort studyElixhauser comorbidity scorePV/ET myelofibrosisRisk regression modelsSAS version 9.4Part D coverage
2014
The Impact of Marital and Socioeconomic Status on Outcomes of Patients with Acute Promyelocytic Leukemia
Huntington S, Shah N, Epstein A, Loren A. The Impact of Marital and Socioeconomic Status on Outcomes of Patients with Acute Promyelocytic Leukemia. Blood 2014, 124: 1282. DOI: 10.1182/blood.v124.21.1282.1282.Peer-Reviewed Original ResearchAcute promyelocytic leukemiaCurable hematological malignancyOutcomes of patientsArea Health Resource FileLong-term survivalHematological malignanciesSocioeconomic statusMarital statusPatient factorsPromyelocytic leukemiaLong-term overall survivalImproved long-term survivalUninsurance ratesIncurable metastatic diseaseCox regression analysisIndividual patient factorsEnd Results ProgramImportant patient factorsMultivariable logistic regressionAcute medical careTiming of presentationLikelihood of deathSocioeconomic factorsSocial supportSocioeconomic status index